Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Mesenchymal stem cells (MSCs) possess significant immunomodulatory and anti-inflammatory properties. These effects are mediated through both direct cell-cell interactions and the secretion of soluble factors, modulating both innate and adaptive immune responses. Key secreted molecules include IDO, PGE2, IL-10, TGF-β, and TSG6. MSCs act as "guardians" at sites of injury or inflammation, controlling local immune responses and facilitating tissue repair. They are being explored for treating inflammatory diseases, but their therapeutic efficacy can be inconsistent.
MSCs exert their anti-inflammatory effects through the secretion of soluble factors (IDO, PGE2, IL-10, TGF-β, TSG6) and direct cell-cell interactions, modulating both innate and adaptive immune responses. This leads to suppression of effector T cell activation/proliferation, promotion of regulatory T cells, reduction in B-cell proliferation and antibody production, polarization of macrophages toward an M2 phenotype, and inhibition of dendritic cell and NK cell activity.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Mesenchymal Stem Cell-Mediated Anti-Inflammatory Effect (MSC-mediated anti-inflammatory effect).